Literature DB >> 23139279

Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.

Jing Yu1, Runsheng Peng, Hui Chen, Chen Cui, Jun Ba.   

Abstract

PURPOSE: To understand the molecular mechanisms of rhegmatogenous retinal detachment (RRD) with proliferative vitreoretinopathy (PVR), the vitreous proteome in RRD patients with severe PVR (grade C or D) was investigated.
METHODS: The analysis of the vitreous proteome in RRD patients with PVR (n = 24) and donor samples (n = 8) was analyzed by one-dimensional (1D) SDS-PAGE and reverse-phase liquid chromatography tandem mass spectrometry (RP-LC-MS/MS). The data were analyzed using GeneGO MetaCore software. The research followed the tenets of the Declaration of Helsinki for the use of human subjects.
RESULTS: In total, 516 and 364 proteins were identified in the vitreous of RRD patients with PVR and donor samples, including 48 overlapping proteins. In the PVR vitreous samples, the levels of extracellular (EC) proteins were increased and the levels of cytoskeleton proteins were decreased. In the pathologic process of PVR, inflammation was identified as an important GeneGo network. Furthermore, the complement and coagulation cascade was the essential pathway. Among the interaction network, the key node proteins in this network were p53 and transcription factor E2F1, respectively.
CONCLUSIONS: 1D-SDS-PAGE coupled with RP-LC-MS/MS is a valuable resource to aid in the characterization of the proteome of RRD patients with PVR. Inflammation is the important pathologic process of PVR, while complement and coagulation cascade was the crucial pathway. p53 and E2F1 may be the new targets for successful treatment of RRD with PVR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139279     DOI: 10.1167/iovs.12-10079

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.

Authors:  Tong Li; Shiqi Yang; Xiangjun She; Quan Yan; Pengfei Zhang; Hong Zhu; Fenghua Wang; Xueting Luo; Xiaodong Sun
Journal:  Br J Pharmacol       Date:  2019-01-30       Impact factor: 8.739

2.  Effects of resveratrol on ARPE-19 cell proliferation and migration via regulating the expression of proliferating cell nuclear antigen, P21, P27 and p38MAPK/MMP-9.

Authors:  Xiao-Ning Hao; Wen-Jie Wang; Jian Chen; Qing Zhou; Yi-Xin Qu; Xiao-Yong Liu; Wei Xu
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Inhibition of the alternative complement pathway preserves photoreceptors after retinal injury.

Authors:  J Harry Sweigard; Hidetaka Matsumoto; Kaylee E Smith; Leo A Kim; Eleftherios I Paschalis; Yoko Okonuki; Alexandra Castillejos; Keiko Kataoka; Eiichi Hasegawa; Ryoji Yanai; Deeba Husain; John D Lambris; Demetrios Vavvas; Joan W Miller; Kip M Connor
Journal:  Sci Transl Med       Date:  2015-07-22       Impact factor: 17.956

4.  Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.

Authors:  Bongsu Kim; Mohamed H Abdel-Rahman; Tiffany Wang; Severin Pouly; Ashraf M Mahmoud; Colleen M Cebulla
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-03       Impact factor: 4.799

5.  Personalized Proteomics in Proliferative Vitreoretinopathy Implicate Hematopoietic Cell Recruitment and mTOR as a Therapeutic Target.

Authors:  C Nathaniel Roybal; Gabriel Velez; Marcus A Toral; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  Am J Ophthalmol       Date:  2017-12-13       Impact factor: 5.258

6.  MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment.

Authors:  Bongsu Kim; Rania Kusibati; Tyler Heisler-Taylor; Dimosthenis Mantopoulos; Jiaxi Ding; Mohamed H Abdel-Rahman; Abhay R Satoskar; Jonathan P Godbout; Sanjoy K Bhattacharya; Colleen M Cebulla
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

Review 7.  Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook.

Authors:  Sarah R Weber; Yuanjun Zhao; Christopher Gates; Jingqun Ma; Felipe da Veiga Leprevost; Venkatesha Basrur; Alexey I Nesvizhskii; Thomas W Gardner; Jeffrey M Sundstrom
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

8.  The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.

Authors:  Salvador Pastor-Idoate; Irene Rodríguez-Hernández; Jimena Rojas; Itziar Fernández; María T García-Gutiérrez; José M Ruiz-Moreno; Amandio Rocha-Sousa; Yashin Ramkissoon; Steven Harsum; Robert E MacLaren; David Charteris; Jan C VanMeurs; Rogelio González-Sarmiento; José C Pastor
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

9.  Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits.

Authors:  Nakul Mandal; Geoffrey P Lewis; Steven K Fisher; Steffen Heegaard; Jan U Prause; Morten la Cour; Henrik Vorum; Bent Honoré
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

Review 10.  Personalized Medicine in Ocular Fibrosis: Myth or Future Biomarkers.

Authors:  Cynthia Yu-Wai-Man; Peng Tee Khaw
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-09-01       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.